ETF Managers Group’s Health Catalyst HCAT Stock Holding History

ETF Managers Group’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20,003	Closed	-$310K	–	744
2022 Q2	$310K	Buy	+20,003	New	+$341K	0.01%	596

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ETF Managers Group's HCAT Position: Q3 2022 in Review

ETF Managers Group sold out of Health Catalyst (HCAT) in Q3 2022, closing a stake of 20,003 shares — an estimated $310K sold.

ETF Managers Group first reported a position in HCAT in Q2 2022 and held it in 1 quarter. The position peaked at $310K in Q2 2022. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.

ETF Managers Group reported no remaining Health Catalyst position as of Q3 2022 after selling out during the quarter.
ETF Managers Group sold 20,003 Health Catalyst shares in Q3 2022, an estimated $310K.
ETF Managers Group first reported a position in Health Catalyst in Q2 2022 and held it in 1 quarter.
ETF Managers Group's Health Catalyst position peaked at $310K in Q2 2022.
171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.

Based on ETF Managers Group's 13F filing for Q3 2022, filed 14 Nov 2022.